- Home
- CRGX vs SSTI Comparison
CRGX vs SSTI Comparison
Compare CRGX & SSTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- SSTI
- Stock Information
- Founded
- CRGX 2021
- SSTI 1996
- Country
- CRGX United States
- SSTI United States
- Employees
- CRGX N/A
- SSTI N/A
- Industry
- CRGX
- SSTI Computer Software: Prepackaged Software
- Sector
- CRGX
- SSTI Technology
- Exchange
- CRGX Nasdaq
- SSTI Nasdaq
- Market Cap
- CRGX 190.0M
- SSTI 196.6M
- IPO Year
- CRGX 2023
- SSTI 2017
- Fundamental
- Price
- CRGX $4.27
- SSTI $15.57
- Analyst Decision
- CRGX Hold
- SSTI Buy
- Analyst Count
- CRGX 7
- SSTI 8
- Target Price
- CRGX $4.67
- SSTI $20.38
- AVG Volume (30 Days)
- CRGX 647.1K
- SSTI 42.5K
- Earning Date
- CRGX 08-11-2025
- SSTI 08-05-2025
- Dividend Yield
- CRGX N/A
- SSTI N/A
- EPS Growth
- CRGX N/A
- SSTI N/A
- EPS
- CRGX N/A
- SSTI N/A
- Revenue
- CRGX N/A
- SSTI $104,970,000.00
- Revenue This Year
- CRGX $58.18
- SSTI $11.41
- Revenue Next Year
- CRGX N/A
- SSTI $8.56
- P/E Ratio
- CRGX N/A
- SSTI N/A
- Revenue Growth
- CRGX N/A
- SSTI 7.65
- 52 Week Low
- CRGX $3.00
- SSTI $9.33
- 52 Week High
- CRGX $25.45
- SSTI $19.43
- Technical
- Relative Strength Index (RSI)
- CRGX 45.02
- SSTI 46.30
- Support Level
- CRGX $4.33
- SSTI $15.50
- Resistance Level
- CRGX $4.48
- SSTI $16.85
- Average True Range (ATR)
- CRGX 0.19
- SSTI 0.64
- MACD
- CRGX -0.02
- SSTI -0.04
- Stochastic Oscillator
- CRGX 21.14
- SSTI 20.59
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.